Kok P, Paulo RC, Cosma M, Mielke KL, Miles JM, Bowers CY, Veldhuis JD
No contienen agonistas de los receptores de GLP-1 y no producirn los mismos efectos que Ozempic o Wegovy (6)
Without controlled studies, we cannot quantify actual efficacy rates
Thorsten Feiweier from Siemens AG, Healthcare for providing the prototype software package for advanced diffusion imaging, which was used to acquire data in this study and Michael Maddock for assistance in development of custom software for MRS data processing
24, 2025 /PRNewswire/ -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression
Patients taking GLP-1 RAs, irrespective of drug type, dose, duration of therapy, and absence of symptoms, can have delayed gastric emptying such that not adjusting fasting times might lead to aspiration events in asymptomatic patients